Has Mark Ghegan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $638 in general payments to Mark Ghegan, MD across 17 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Ghegan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Ghegan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Ghegan, MD

Otolaryngology · Charleston, SCNPI 1043308448

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Stryker at 32.9% of the total. 2025 is the largest year on record at $327, 4.9 times the $67 reported in 2019. That places this record below the midpoint for otolaryngology clinicians in SC, where the typical reported total is $1,243.

$638in general payments, 2019–2025

Across 17 payments — averaging $37.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$210
Neurent Medical Limited$114
Sanofi$92
Pharming Healthcare, Inc.$49
Intersect ENT, Inc.$42
Regeneron Healthcare Solutions, Inc.$39
plus $92 from 4 others

$32,760in ownership & investment interests, 2019–2025

Across 7 payments — averaging $4680.00 each. An ownership or investment interest held by the physician or an immediate family member.

The North Carolina Mutual Wholesale Drug Company Inc$33K

What the payments were for

Food & beverage$638100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	3	$210
Neurent Medical Limited	2	$114
Sanofi	3	$92
Pharming Healthcare, Inc.	2	$49
Intersect ENT, Inc.	1	$42
Regeneron Healthcare Solutions, Inc.	1	$39
GSK	2	$34
Novartis	1	$25
Optinose US, Inc.	1	$17
AstraZeneca	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SCOPIS ENT$176

How this compares

$638 in reported general payments places this provider in the 35th percentile of 180 otolaryngology providers in South Carolina.

See all otolaryngology providers in South Carolina →

Medicare billing

Part B allowed, 2024

$258,957

Medicare patients

897

Services billed

3,388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	134	$5,009
Azelastine Hcl	207	$4,814
Famotidine	107	$1,457
Fluticasone Propionate	93	$1,363
Prednisolone	33	$1,318
Dexamethasone Sodium Phosphate	16	$940
Prednisone	127	$548
Cefdinir	35	$544
Omeprazole	33	$433
Mupirocin	63	$364
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	37	$309
Doxycycline Hyclate	28	$303
Fluocinolone Acetonide Oil	13	$288
Esomeprazole Magnesium	13	$160
Prednisolone Sodium Phosphate	13	$104

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Charleston

Shaun NguyenCharleston$973K
Rodney SchlosserCharleston$382K
Zachary SolerCharleston$67K
Eugene BrownCharleston$28K
Jason NewmanCharleston$26K
Joshua HornigCharleston$25K
Ashli OrourkeCharleston$21K
Alexandra KejnerCharleston$19K
Evan GraboyesCharleston$18K
Mohamed AbdelwahabCharleston$15K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →